Stolbrink, M;
Chinouya, MJ;
Jayasooriya, S;
Nightingale, R;
Evans-Hill, L;
Allan, K;
Allen, H;
... Mortimer, K; + view all
(2022)
Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries.
The International Journal of Tuberculosis and Lung Disease
, 26
(11)
pp. 1023-1032.
10.5588/ijtld.22.0270.
Preview |
Text
Hurst_Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries_VoR.pdf - Published Version Download (1MB) | Preview |
Abstract
BACKGROUND: Access to affordable inhaled medicines for chronic respiratory diseases (CRDs) is severely limited in low- and middle-income countries (LMICs), causing avoidable morbidity and mortality. The International Union Against Tuberculosis and Lung Disease convened a stakeholder meeting on this topic in February 2022.METHODS: Focused group discussions were informed by literature and presentations summarising experiences of obtaining inhaled medicines in LMICs. The virtual meeting was moderated using a topic guide around barriers and solutions to improve access. The thematic framework approach was used for analysis.RESULTS: A total of 58 key stakeholders, including patients, healthcare practitioners, members of national and international organisations, industry and WHO representatives attended the meeting. There were 20 pre-meeting material submissions. The main barriers identified were 1) low awareness of CRDs; 2) limited data on CRD burden and treatments in LMICs; 3) ineffective procurement and distribution networks; and 4) poor communication of the needs of people with CRDs. Solutions discussed were 1) generation of data to inform policy and practice; 2) capacity building; 3) improved procurement mechanisms; 4) strengthened advocacy practices; and 5) a World Health Assembly Resolution.CONCLUSION: There are opportunities to achieve improved access to affordable, quality-assured inhaled medicines in LMICs through coordinated, multi-stakeholder, collaborative efforts.
| Type: | Article |
|---|---|
| Title: | Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries |
| Location: | France |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.5588/ijtld.22.0270 |
| Publisher version: | https://doi.org/10.5588/ijtld.22.0270 |
| Language: | English |
| Additional information: | This article is Open Access under the terms of the Creative Commons CC BY licence. (https://creativecommons.org/licenses/by/4.0/) |
| Keywords: | Humans, Developing Countries, Income, Poverty, Global Health, Respiration Disorders |
| UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10158408 |
Loading...
Loading...Loading...Loading...Archive Staff Only
 |
View Item |
